epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Entresto Sprinkle

sacubitril/ valsartan

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Fetal Toxicity

fetal/neonatal morbidity/mortality may occur when drugs that act directly on the renin-angiotensin system are used in pregnancy; D/C drug ASAP once pregnancy detected

Adult Dosing .

Adult dosing is currently unavailable or not applicable for this drug.

Peds Dosing .

Dosage forms:  PELLET: 6 mg/6 mg per cap, 15 mg/16 mg per cap

heart failure, symptomatic with left ventricular systolic dysfunction

[patients converting from usual dose ACE inhibitor or ARB tx, 1 yo and older, 13-18.9 kg]
Dose: 24 mg/24 mg PO bid; Start: 12 mg/12 mg PO bid x2wk, then 18 mg/18 mg PO bid x2wk, then 24 mg/24 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from usual dose ACE inhibitor or ARB tx, 1 yo and older, 19-25.9 kg]
Dose: 30 mg/32 mg PO bid; Start: 18 mg/18 mg PO bid x2wk, then 24 mg/24 mg PO bid x2wk, then 30 mg/32 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from usual dose ACE inhibitor or ARB tx, 1 yo and older, 26-33.9 kg]
Dose: 45 mg/48 mg PO bid; Start: 24 mg/24 mg PO bid x2wk, then 30 mg/32 mg PO bid x2wk, then 45 mg/48 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from usual dose ACE inhibitor or ARB tx, 1 yo and older, 34-49.9 kg]
Dose: 60 mg/64 mg PO bid; Start: 30 mg/32 mg PO bid x2wk, then 45 mg/48 mg PO bid x2wk, then 60 mg/64 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from low dose ACE inhibitor or ARB tx, 1 yo and older, 13-18.9 kg]
Dose: 24 mg/24 mg PO bid; Start: 6 mg/6 mg PO bid x2wk, then 12 mg/12 mg PO bid x2wk, then 18 mg/18 mg PO bid x2wk, then 24 mg/24 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from low dose ACE inhibitor or ARB tx, 1 yo and older, 19-25.9 kg]
Dose: 30 mg/32 mg PO bid; Start: 9 mg/9 mg PO bid x2wk, then 18 mg/18 mg PO bid x2wk, then 24 mg/24 mg PO bid x2wk, then 30 mg/32 mg PO bid; Info: must open cap, but do not chew/crush pellet; may use oral suspension preparation from tab form for start dose; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from low dose ACE inhibitor or ARB tx, 1 yo and older, 26-33.9 kg]
Dose: 45 mg/48 mg PO bid; Start: 12 mg/12 mg PO bid x2wk, then 24 mg/24 mg PO bid x2wk, then 30 mg/32 mg PO bid x2wk, then 45 mg/48 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients converting from low dose ACE inhibitor or ARB tx, 1 yo and older, 34-49.9 kg]
Dose: 60 mg/64 mg PO bid; Start: 15 mg/16 mg PO bid x2wk, then 30 mg/32 mg PO bid x2wk, then 45 mg/48 mg PO bid x2wk, then 60 mg/64 mg PO bid; Info: must open cap, but do not chew/crush pellet; for patients converting from ACE inhibitor, start 36h after ACE inhibitor tx D/C
[patients currently not receiving ACE inhibitor or ARB tx, 1 yo and older, 13-18.9 kg]
Dose: 24 mg/24 mg PO bid; Start: 6 mg/6 mg PO bid x2wk, then 12 mg/12 mg PO bid x2wk, then 18 mg/18 mg PO bid x2wk, then 24 mg/24 mg PO bid; Info: must open cap, but do not chew/crush pellet
[patients currently not receiving ACE inhibitor or ARB tx, 1 yo and older, 19-25.9 kg]
Dose: 30 mg/32 mg PO bid; Start: 9 mg/9 mg PO bid x2wk, then 18 mg/18 mg PO bid x2wk, then 24 mg/24 mg PO bid x2wk, then 30 mg/32 mg PO bid; Info: must open cap, but do not chew/crush pellet; may use oral suspension preparation from tab form for start dose
[patients currently not receiving ACE inhibitor or ARB tx, 1 yo and older, 26-33.9 kg]
Dose: 45 mg/48 mg PO bid; Start: 12 mg/12 mg PO bid x2wk, then 24 mg/24 mg PO bid x2wk, then 30 mg/32 mg PO bid x2wk, then 45 mg/48 mg PO bid; Info: must open cap, but do not chew/crush pellet
[patients currently not receiving ACE inhibitor or ARB tx, 1 yo and older, 34-49.9 kg]
Dose: 60 mg/64 mg PO bid; Start: 15 mg/16 mg PO bid x2wk, then 30 mg/32 mg PO bid x2wk, then 45 mg/48 mg PO bid x2wk, then 60 mg/64 mg PO bid; Info: must open cap, but do not chew/crush pellet

renal dosing

[patients converting from usual dose ACE inhibitor or ARB tx]
eGFR <30: decr. usual start dose by 50%, then incr. dose q2wk following usual dose escalation
HD/PD: not defined
[all other patients]
renal impairment: no adjustment
HD/PD: not defined

hepatic dosing

[patients converting from usual dose ACE inhibitor or ARB tx]
Child-Pugh Class B: decr. usual start dose by 50%, then incr. dose q2wk following usual dose escalation; Child-Pugh Class C: avoid use
[all other patients]
Child-Pugh Class C: avoid use

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@165c274d
  • hypersensitivity to drug or ingredient
  • angioedema history, ACE inhibitor-associated
  • angioedema history, ARB-associated
  • angioedema, hereditary
  • pregnancy
  • breastfeeding
  • hepatic impairment, Child-Pugh Class C
  • caution: hepatic impairment, Child-Pugh Class B (patient converting from usual dose ACE inhibitor or ARB tx)
  • caution: renal artery stenosis
  • caution: renal impairment
  • caution: volume depletion
  • caution: hyponatremia
  • caution: hyperkalemia risk
  • caution: hypotension
  • caution: post-MI

Drug Interactions .

Overview

sacubitril

neprilysin inhibitor

Interaction Characteristics:
  • OATP1B1 inhibitor, weak
  • OATP1B3 inhibitor, weak
  • angioedema
  • vasodilator agent

valsartan

ARB

Interaction Characteristics:
  • MRP2 substrate
  • OATP1B1 substrate
  • OATP1B3 substrate
  • angiotensin II Type 1 antagonist
  • antihypertensive agent
  • decreases renal perfusion/fxn
  • hyperkalemia
  • hypoglycemic effects

Contraindicated

  • aliskiren
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aliskiren
    2 interactions

    Contraindicated

    valsartan + aliskiren

    contraindicated in diabetic patients; avoid combo in pts w/ CrCl <60; for all other pts, use alternative or monitor BP, potassium, renal fxn: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

    Monitor/Modify Tx

    sacubitril + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • benazepril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    benazepril
    2 interactions

    Contraindicated

    sacubitril + benazepril

    contraindicated w/in 36h of benazepril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + benazepril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • captopril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    captopril
    2 interactions

    Contraindicated

    sacubitril + captopril

    contraindicated w/in 36h of captopril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + captopril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • enalapril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    enalapril
    2 interactions

    Contraindicated

    sacubitril + enalapril

    contraindicated w/in 36h of enalapril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + enalapril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • enalaprilat
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    enalaprilat
    2 interactions

    Contraindicated

    sacubitril + enalaprilat

    contraindicated w/in 36h of enalaprilat use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + enalaprilat

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • fosinopril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fosinopril
    2 interactions

    Contraindicated

    sacubitril + fosinopril

    contraindicated w/in 36h of fosinopril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + fosinopril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • grazoprevir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    grazoprevir
    1 interaction

    Contraindicated

    sacubitril + grazoprevir

    contraindicated: combo may incr. grazoprevir levels, risk of adverse effects (hepatic transport inhibited)

  • isocarboxazid
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    isocarboxazid
    2 interactions

    Contraindicated

    valsartan + isocarboxazid

    contraindicated: combo may incr. risk of hypotension, including orthostasis (additive effects)

    Monitor/Modify Tx

    sacubitril + isocarboxazid

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lisinopril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lisinopril
    2 interactions

    Contraindicated

    sacubitril + lisinopril

    contraindicated w/in 36h of lisinopril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + lisinopril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • moexipril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    moexipril
    2 interactions

    Contraindicated

    sacubitril + moexipril

    contraindicated w/in 36h of moexipril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + moexipril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • perindopril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    perindopril
    2 interactions

    Contraindicated

    sacubitril + perindopril

    contraindicated w/in 36h of perindopril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + perindopril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • quinapril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    quinapril
    2 interactions

    Contraindicated

    sacubitril + quinapril

    contraindicated w/in 36h of quinapril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + quinapril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • ramipril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ramipril
    2 interactions

    Contraindicated

    sacubitril + ramipril

    contraindicated w/in 36h of ramipril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + ramipril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

  • sparsentan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sparsentan
    2 interactions

    Contraindicated

    valsartan + sparsentan

    contraindicated: combo may incr. risk of hyperkalemia, nephrotoxicity, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    trandolapril
    2 interactions

    Contraindicated

    sacubitril + trandolapril

    contraindicated w/in 36h of trandolapril use: combo may incr. risk of angioedema, hypotension, including orthostasis (additive effects)

    Avoid/Use Alternative

    valsartan + trandolapril

    use alternative or monitor BP, renal fxn, electrolytes: combo may incr. risk of hypotension, hyperkalemia, renal impairment without additional benefit (additive effects, dual blockade of renin-angiotensin-aldosterone system)

Avoid/Use Alternative

  • aldesleukin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aldesleukin
    2 interactions

    Avoid/Use Alternative

    sacubitril + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

    valsartan + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • amikacin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    valsartan + amikacin

    use alternative or monitor amikacin levels, renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amiloride
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amiloride
    2 interactions

    Avoid/Use Alternative

    valsartan + amiloride

    if hypokalemia use, consider alternative or monitor potassium; otherwise, avoid combo: combo may incr. risk of hyperkalemia (additive effects)

    Monitor/Modify Tx

    sacubitril + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • angiotensin II
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    angiotensin II
    1 interaction

    Avoid/Use Alternative

    valsartan + angiotensin II

    use alternative or monitor BP: combo may decr. angiotensin II efficacy (antagonistic effects)

  • aripiprazole lauroxil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aripiprazole lauroxil
    2 interactions

    Avoid/Use Alternative

    valsartan + aripiprazole lauroxil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    Monitor/Modify Tx

    sacubitril + aripiprazole lauroxil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • atrasentan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    atrasentan
    1 interaction

    Avoid/Use Alternative

    sacubitril + atrasentan

    avoid combo: combo may incr. atrasentan levels, risk of adverse effects (hepatic transport inhibited)

  • azilsartan medoxomil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    azilsartan medoxomil
    2 interactions

    Avoid/Use Alternative

    valsartan + azilsartan medoxomil

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • brincidofovir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    brincidofovir
    1 interaction

    Avoid/Use Alternative

    sacubitril + brincidofovir

    consider alternative or monitor LFTs, GI toxicity sx; give brincidofovir at least 3h before sacubitril: combo may incr. brincidofovir levels, risk of hepatotoxicity, GI toxicity, other adverse effects (hepatic transport inhibited)

  • candesartan cilexetil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    candesartan cilexetil
    2 interactions

    Avoid/Use Alternative

    valsartan + candesartan cilexetil

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • celecoxib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    celecoxib
    1 interaction

    Avoid/Use Alternative

    valsartan + celecoxib

    consider alternative or monitor potassium, renal fxn, BP: combo may incr. risk of hyperkalemia, renal impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • clofarabine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    clofarabine
    2 interactions

    Avoid/Use Alternative

    valsartan + clofarabine

    avoid valsartan during 5 day clofarabine tx; monitor CBC, renal fxn, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, severe hypotension, other adverse effects (additive effects)

    Monitor/Modify Tx

    sacubitril + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • cyclosporine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cyclosporine
    1 interaction

    Avoid/Use Alternative

    valsartan + cyclosporine

    consider alternative or monitor potassium, renal fxn, BP: combo may incr. valsartan levels, risk of hyperkalemia, nephrotoxicity, other adverse effects; may decr. antihypertensive agent efficacy (hepatic transport inhibited, MRP2-mediated transport inhibited, additive effects; antagonistic effects)

  • diclofenac
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    diclofenac
    1 interaction

    Avoid/Use Alternative

    valsartan + diclofenac

    consider alternative or monitor potassium, renal fxn, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • diclofenac topical
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    diclofenac topical
    1 interaction

    Avoid/Use Alternative

    valsartan + diclofenac topical

    consider alternative or monitor potassium, renal fxn, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • diflunisal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    diflunisal
    1 interaction

    Avoid/Use Alternative

    valsartan + diflunisal

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • drospirenone (contraceptive)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    drospirenone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    valsartan + drospirenone (contraceptive)

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • drospirenone (hormone replacement)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    drospirenone (hormone replacement)
    1 interaction

    Avoid/Use Alternative

    valsartan + drospirenone (hormone replacement)

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • elagolix
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    elagolix
    1 interaction

    Avoid/Use Alternative

    sacubitril + elagolix

    consider alternative: combo may incr. elagolix levels, risk of adverse effects (hepatic transport inhibited)

  • eplerenone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    eplerenone
    2 interactions

    Avoid/Use Alternative

    valsartan + eplerenone

    consider alternative or monitor potassium, renal fxn: combo may incr. risk of hyperkalemia (additive effects)

    Monitor/Modify Tx

    sacubitril + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • etodolac
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    etodolac
    1 interaction

    Avoid/Use Alternative

    valsartan + etodolac

    consider alternative or monitor BP, renal fxn, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of renal impairment, hyperkalemia (antagonistic effects; additive effects)

  • fenoprofen
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fenoprofen
    1 interaction

    Avoid/Use Alternative

    valsartan + fenoprofen

    consider alternative or monitor BP, renal fxn, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of renal impairment, hyperkalemia (additive effects; antagonistic effects)

  • flurbiprofen
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    flurbiprofen
    1 interaction

    Avoid/Use Alternative

    valsartan + flurbiprofen

    consider alternative or monitor BP, renal fxn, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of renal impairment, hyperkalemia (antagonistic effects; additive effects)

  • heparin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    heparin
    1 interaction

    Avoid/Use Alternative

    valsartan + heparin

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • ibuprofen
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ibuprofen
    1 interaction

    Avoid/Use Alternative

    valsartan + ibuprofen

    consider alternative or monitor BP, renal fxn, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of renal impairment, hyperkalemia (antagonistic effects; additive effects)

  • indomethacin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    indomethacin
    1 interaction

    Avoid/Use Alternative

    valsartan + indomethacin

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • irbesartan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    irbesartan
    2 interactions

    Avoid/Use Alternative

    valsartan + irbesartan

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ketoprofen
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ketoprofen
    1 interaction

    Avoid/Use Alternative

    valsartan + ketoprofen

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • ketorolac
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ketorolac
    1 interaction

    Avoid/Use Alternative

    valsartan + ketorolac

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • landiolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    landiolol
    2 interactions

    Avoid/Use Alternative

    valsartan + landiolol

    consider alternative or monitor BP, potassium, especially if renal impairment: combo may incr. risk of hypotension, hyperkalemia (additive effects)

    Monitor/Modify Tx

    sacubitril + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lofexidine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lofexidine
    2 interactions

    Avoid/Use Alternative

    sacubitril + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • losartan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    losartan
    2 interactions

    Avoid/Use Alternative

    valsartan + losartan

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meclofenamate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    meclofenamate
    1 interaction

    Avoid/Use Alternative

    valsartan + meclofenamate

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • mefenamic acid
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mefenamic acid
    1 interaction

    Avoid/Use Alternative

    valsartan + mefenamic acid

    consider alternative or monitor BP, renal fxn, potassium: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • meloxicam
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    meloxicam
    1 interaction

    Avoid/Use Alternative

    valsartan + meloxicam

    consider alternative or monitor potassium, renal fxn, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • nabumetone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nabumetone
    1 interaction

    Avoid/Use Alternative

    valsartan + nabumetone

    consider alternative or monitor BP, renal fxn, potassium: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • naproxen
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    naproxen
    1 interaction

    Avoid/Use Alternative

    valsartan + naproxen

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • nilotinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nilotinib
    1 interaction

    Avoid/Use Alternative

    valsartan + nilotinib

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • olmesartan medoxomil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    olmesartan medoxomil
    2 interactions

    Avoid/Use Alternative

    valsartan + olmesartan medoxomil

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oxaprozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxaprozin
    1 interaction

    Avoid/Use Alternative

    valsartan + oxaprozin

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • piroxicam
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    piroxicam
    1 interaction

    Avoid/Use Alternative

    valsartan + piroxicam

    consider alternative or monitor BP, renal fxn, potassium: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • potassium acid phosphate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    potassium acid phosphate
    1 interaction

    Avoid/Use Alternative

    valsartan + potassium acid phosphate

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • potassium bicarbonate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    potassium bicarbonate
    1 interaction

    Avoid/Use Alternative

    valsartan + potassium bicarbonate

    consider alternative or monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium chloride
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    potassium chloride
    1 interaction

    Avoid/Use Alternative

    valsartan + potassium chloride

    IV potassium chloride: use alternative or monitor potassium, ECG; ORAL potassium: consider alternative or monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium citrate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    potassium citrate
    1 interaction

    Avoid/Use Alternative

    valsartan + potassium citrate

    consider alternative or monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium iodide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    potassium iodide
    1 interaction

    Avoid/Use Alternative

    valsartan + potassium iodide

    consider alternative or monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • potassium phosphate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    potassium phosphate
    1 interaction

    Avoid/Use Alternative

    valsartan + potassium phosphate

    use alternative or monitor potassium, ECG: combo may incr. risk of severe hyperkalemia, cardiac arrest (additive effects)

  • spironolactone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    spironolactone
    2 interactions

    Avoid/Use Alternative

    valsartan + spironolactone

    consider alternative or monitor renal fxn, potassium: combo may incr. risk of renal impairment, severe hyperkalemia (additive effects)

    Monitor/Modify Tx

    sacubitril + spironolactone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sulindac
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sulindac
    1 interaction

    Avoid/Use Alternative

    valsartan + sulindac

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tacrolimus
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tacrolimus
    1 interaction

    Avoid/Use Alternative

    valsartan + tacrolimus

    consider alternative or monitor tacrolimus levels, renal fxn, potassium, BP: combo may incr. tacrolimus levels, risk of nephrotoxicity, hyperkalemia, other adverse effects; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • telmisartan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    telmisartan
    2 interactions

    Avoid/Use Alternative

    valsartan + telmisartan

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + telmisartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tolmetin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tolmetin
    1 interaction

    Avoid/Use Alternative

    valsartan + tolmetin

    consider alternative or monitor renal fxn, potassium, BP: combo may incr. risk of renal impairment, hyperkalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • tolvaptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tolvaptan
    1 interaction

    Avoid/Use Alternative

    valsartan + tolvaptan

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • triamterene
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    triamterene
    2 interactions

    Avoid/Use Alternative

    valsartan + triamterene

    consider alternative or monitor potassium: combo may incr. risk of severe hyperkalemia (additive effects)

    Monitor/Modify Tx

    sacubitril + triamterene

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trimethoprim
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    trimethoprim
    1 interaction

    Avoid/Use Alternative

    valsartan + trimethoprim

    consider alternative or monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • valsartan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    valsartan
    2 interactions

    Avoid/Use Alternative

    valsartan + valsartan

    avoid combo: combo may incr. risk of hyperkalemia, renal impairment, other adverse effects (additive effects, duplicate therapy)

    Monitor/Modify Tx

    sacubitril + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • voclosporin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    voclosporin
    1 interaction

    Avoid/Use Alternative

    valsartan + voclosporin

    consider alternative or monitor potassium, renal fxn, BP: combo may incr. risk of severe hyperkalemia, nephrotoxicity; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • zavegepant
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    zavegepant
    2 interactions

    Avoid/Use Alternative

    sacubitril + zavegepant

    avoid combo: combo may incr. zavegepant levels, risk of adverse effects (hepatic transport inhibited)

    Monitor/Modify Tx

    valsartan + zavegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Monitor/Modify Tx

  • abiraterone acetate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    valsartan + abiraterone acetate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • acebutolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + acebutolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • acyclovir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    valsartan + acyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    valsartan + adefovir dipivoxil

    monitor renal fxn: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased, additive effects)

  • albuterol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    valsartan + albuterol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + albuterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • alfentanil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    alfentanil
    2 interactions

    Monitor/Modify Tx

    sacubitril + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    alfuzosin
    2 interactions

    Monitor/Modify Tx

    sacubitril + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • almotriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + almotriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    alprostadil intracavernous
    2 interactions

    Monitor/Modify Tx

    sacubitril + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

    valsartan + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amantadine
    2 interactions

    Monitor/Modify Tx

    sacubitril + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amifostine
    2 interactions

    Monitor/Modify Tx

    sacubitril + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + amifostine

    D/C valsartan 24h before amifostine admin.; monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • amikacin inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amikacin inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + amikacin inhaled

    monitor renal fxn, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amitriptyline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amitriptyline
    2 interactions

    Monitor/Modify Tx

    sacubitril + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amlodipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amoxapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amphetamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    valsartan + amphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphotericin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    valsartan + amphotericin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • anthrax immune globulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    valsartan + anthrax immune globulin

    monitor renal fxn; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • apomorphine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    apomorphine
    2 interactions

    Monitor/Modify Tx

    sacubitril + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    apraclonidine ophthalmic
    2 interactions

    Monitor/Modify Tx

    sacubitril + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension (additive effects)

  • aprocitentan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    sacubitril + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • arformoterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + arformoterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • aripiprazole bimonthly injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aripiprazole bimonthly injection
    2 interactions

    Monitor/Modify Tx

    sacubitril + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole monthly injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aripiprazole monthly injection
    2 interactions

    Monitor/Modify Tx

    sacubitril + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aripiprazole oral
    2 interactions

    Monitor/Modify Tx

    sacubitril + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • armodafinil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    valsartan + armodafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • articaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    articaine
    2 interactions

    Monitor/Modify Tx

    sacubitril + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + articaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • asciminib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    valsartan + asciminib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • asenapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    asenapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aspirin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    valsartan + aspirin

    monitor BP, renal fxn: combo may incr. risk of renal impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • atenolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • atogepant
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    atogepant
    2 interactions

    Monitor/Modify Tx

    sacubitril + atogepant

    CHRONIC MIGRAINE: decr. atogepant dose to 30 mg/day; EPISODIC MIGRAINE: decr. atogepant dose to 10 or 30 mg/day: combo may incr. atogepant levels, risk of adverse effects (hepatic transport inhibited)

    valsartan + atogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    valsartan + atomoxetine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atorvastatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    atorvastatin
    1 interaction

    Monitor/Modify Tx

    sacubitril + atorvastatin

    monitor CK, myopathy sx: combo may incr. atorvastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (hepatic transport inhibited)

  • atropine ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    valsartan + atropine ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • auranofin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    valsartan + auranofin

    monitor renal fxn: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avanafil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    avanafil
    2 interactions

    Monitor/Modify Tx

    sacubitril + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • axitinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    valsartan + axitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • balsalazide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    valsartan + balsalazide

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • benzphetamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    valsartan + benzphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • berberine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    berberine
    2 interactions

    Monitor/Modify Tx

    sacubitril + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + berberine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • betamethasone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    valsartan + betamethasone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • betaxolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    betaxolol ophthalmic
    2 interactions

    Monitor/Modify Tx

    sacubitril + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bethanechol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bethanechol
    2 interactions

    Monitor/Modify Tx

    sacubitril + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + bethanechol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bevacizumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    valsartan + bevacizumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bexagliflozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bexagliflozin
    2 interactions

    Monitor/Modify Tx

    sacubitril + bexagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + bexagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bismuth subsalicylate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    valsartan + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bisoprolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bortezomib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bortezomib
    2 interactions

    Monitor/Modify Tx

    sacubitril + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • botulism immune globulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    valsartan + botulism immune globulin

    monitor renal fxn; use lowest botulism immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • brexpiprazole
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    brexpiprazole
    2 interactions

    Monitor/Modify Tx

    sacubitril + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brigatinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    valsartan + brigatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brimonidine ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    brimonidine ophthalmic
    2 interactions

    Monitor/Modify Tx

    sacubitril + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

    valsartan + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • brimonidine topical
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    brimonidine topical
    2 interactions

    Monitor/Modify Tx

    sacubitril + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bromocriptine
    2 interactions

    Monitor/Modify Tx

    sacubitril + bromocriptine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + bromocriptine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • budesonide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    valsartan + budesonide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bumetanide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bumetanide
    2 interactions

    Monitor/Modify Tx

    sacubitril + bumetanide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + bumetanide

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • bupivacaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bupivacaine
    2 interactions

    Monitor/Modify Tx

    sacubitril + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + bupivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bupivacaine liposomal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bupivacaine liposomal
    2 interactions

    Monitor/Modify Tx

    sacubitril + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • buprenorphine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    buprenorphine
    2 interactions

    Monitor/Modify Tx

    sacubitril + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • bupropion
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    valsartan + bupropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • butorphanol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    butorphanol
    2 interactions

    Monitor/Modify Tx

    sacubitril + butorphanol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + butorphanol

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • cabergoline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cabergoline
    2 interactions

    Monitor/Modify Tx

    sacubitril + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabozantinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    valsartan + cabozantinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    valsartan + caffeine

    monitor BP; avoid excessive caffeine intake: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine citrate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    valsartan + caffeine citrate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • canagliflozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    canagliflozin
    2 interactions

    Monitor/Modify Tx

    sacubitril + canagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + canagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cannabis
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cannabis
    2 interactions

    Monitor/Modify Tx

    sacubitril + cannabis

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + cannabis

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • capecitabine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    valsartan + capecitabine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • carboplatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    valsartan + carboplatin

    monitor CBC, renal fxn, ototoxicity: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    valsartan + carfilzomib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cariprazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cariprazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    carteolol ophthalmic
    2 interactions

    Monitor/Modify Tx

    sacubitril + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • carvedilol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    sacubitril + carvedilol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chloroprocaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    chloroprocaine
    2 interactions

    Monitor/Modify Tx

    sacubitril + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + chloroprocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • chlorothiazide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    chlorothiazide
    2 interactions

    Monitor/Modify Tx

    sacubitril + chlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + chlorothiazide

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • chlorpromazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    chlorpromazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    chlorthalidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + chlorthalidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + chlorthalidone

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • cidofovir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cidofovir
    1 interaction

    Monitor/Modify Tx

    valsartan + cidofovir

    monitor CBC, renal fxn: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • cilostazol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cilostazol
    2 interactions

    Monitor/Modify Tx

    sacubitril + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + cilostazol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cisplatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    valsartan + cisplatin

    monitor CBC, renal fxn, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • clevidipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clindamycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    valsartan + clindamycin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clomipramine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    clomipramine
    2 interactions

    Monitor/Modify Tx

    sacubitril + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clonidine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    clonidine
    2 interactions

    Monitor/Modify Tx

    sacubitril + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    clozapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + clozapine

    monitor BP, HR: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + clozapine

    monitor BP, HR: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cocaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    valsartan + cocaine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • codeine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    codeine
    2 interactions

    Monitor/Modify Tx

    sacubitril + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    coenzyme Q-10
    2 interactions

    Monitor/Modify Tx

    sacubitril + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • colistimethate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    valsartan + colistimethate

    monitor renal fxn: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • copanlisib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    valsartan + copanlisib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects, copanlisib may cause infusion-related HTN)

  • copper histidinate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    valsartan + copper histidinate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • corticotropin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    valsartan + corticotropin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cortisone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    valsartan + cortisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • creatine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    valsartan + creatine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • cyclophosphamide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    valsartan + cyclophosphamide

    monitor CBC, renal, cardiac fxn: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • cytomegalovirus immune globulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    valsartan + cytomegalovirus immune globulin

    monitor renal fxn; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • danazol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    valsartan + danazol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dapagliflozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dapagliflozin
    2 interactions

    Monitor/Modify Tx

    sacubitril + dapagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + dapagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • darbepoetin alfa
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    valsartan + darbepoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • darolutamide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    darolutamide
    1 interaction

    Monitor/Modify Tx

    valsartan + darolutamide

    monitor potassium: combo may incr. valsartan levels, risk of hyperkalemia, other adverse effects (hepatic transport inhibited)

  • decitabine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    valsartan + decitabine

    monitor potassium w/ IV decitabine use: combo may incr. risk of hyperkalemia (additive effects)

  • deferasirox
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    valsartan + deferasirox

    monitor CBC, renal fxn, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    valsartan + deferoxamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • deflazacort
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    valsartan + deflazacort

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • denileukin diftitox
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    denileukin diftitox
    2 interactions

    Monitor/Modify Tx

    sacubitril + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    desflurane
    2 interactions

    Monitor/Modify Tx

    sacubitril + desflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + desflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • desipramine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    desipramine
    2 interactions

    Monitor/Modify Tx

    sacubitril + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desmopressin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    valsartan + desmopressin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • desvenlafaxine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    valsartan + desvenlafaxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dexamethasone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    valsartan + dexamethasone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dexmedetomidine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dexmedetomidine
    2 interactions

    Monitor/Modify Tx

    sacubitril + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dexmedetomidine injection
    2 interactions

    Monitor/Modify Tx

    sacubitril + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

    valsartan + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • dexmethylphenidate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    valsartan + dexmethylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dextroamphetamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    valsartan + dextroamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diazoxide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    valsartan + diazoxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • diethylpropion
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    valsartan + diethylpropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dihydrocodeine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dihydrocodeine
    2 interactions

    Monitor/Modify Tx

    sacubitril + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • dihydroergotamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    valsartan + dihydroergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diltiazem
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    sacubitril + diltiazem

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dinutuximab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dinutuximab
    2 interactions

    Monitor/Modify Tx

    sacubitril + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • dipyridamole
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dipyridamole
    2 interactions

    Monitor/Modify Tx

    sacubitril + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • doxapram
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    valsartan + doxapram

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxazosin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    doxazosin
    2 interactions

    Monitor/Modify Tx

    sacubitril + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    doxepin
    2 interactions

    Monitor/Modify Tx

    sacubitril + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dronabinol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    dronabinol
    2 interactions

    Monitor/Modify Tx

    sacubitril + dronabinol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + dronabinol

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • droxidopa
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    valsartan + droxidopa

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • duloxetine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    duloxetine
    2 interactions

    Monitor/Modify Tx

    sacubitril + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • eletriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + eletriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • eluxadoline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    eluxadoline
    1 interaction

    Monitor/Modify Tx

    sacubitril + eluxadoline

    decr. eluxadoline dose to 75 mg bid: combo may incr. eluxadoline levels, risk of adverse effects (hepatic transport inhibited)

  • empagliflozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    empagliflozin
    2 interactions

    Monitor/Modify Tx

    sacubitril + empagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + empagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • entacapone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    entacapone
    2 interactions

    Monitor/Modify Tx

    sacubitril + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    entrectinib
    2 interactions

    Monitor/Modify Tx

    sacubitril + entrectinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + entrectinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • ephedra
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    valsartan + ephedra

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    valsartan + ephedrine injection

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine oral
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    valsartan + ephedrine oral

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epinephrine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    valsartan + epinephrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epinephrine inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    epinephrine inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + epinephrine inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    valsartan + epoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoprostenol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    epoprostenol
    2 interactions

    Monitor/Modify Tx

    sacubitril + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • eptinezumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    valsartan + eptinezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • erenumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    valsartan + erenumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ergotamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    valsartan + ergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ertugliflozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ertugliflozin
    2 interactions

    Monitor/Modify Tx

    sacubitril + ertugliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + ertugliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • esketamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    valsartan + esketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • esmolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • estetrol (contraceptive)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    valsartan + estetrol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    valsartan + estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethacrynic acid
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ethacrynic acid
    2 interactions

    Monitor/Modify Tx

    sacubitril + ethacrynic acid

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + ethacrynic acid

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • ethanol (alcoholic beverage)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ethanol (alcoholic beverage)
    2 interactions

    Monitor/Modify Tx

    sacubitril + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + ethanol (alcoholic beverage)

    monitor BP: combo may alter BP control, initially incr. risk of severe hypotension, followed by HTN (additive effects, antagonistic effects, acute alcohol intake may have biphasic effects on blood pressure; chronic alcohol use may further increase HTN risk)

  • ethanol injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ethanol injection
    2 interactions

    Monitor/Modify Tx

    sacubitril + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ethinyl estradiol (contraceptive)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    valsartan + ethinyl estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etrasimod
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    valsartan + etrasimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etripamil nasal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    etripamil nasal
    2 interactions

    Monitor/Modify Tx

    sacubitril + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • felodipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fenfluramine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    valsartan + fenfluramine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoldopam
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    sacubitril + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fentanyl
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fentanyl
    2 interactions

    Monitor/Modify Tx

    sacubitril + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ferumoxytol
    2 interactions

    Monitor/Modify Tx

    sacubitril + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + ferumoxytol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • finerenone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    finerenone
    1 interaction

    Monitor/Modify Tx

    valsartan + finerenone

    monitor potassium: combo may incr. risk of hyperkalemia (additive effects)

  • fingolimod
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    valsartan + fingolimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • flaxseed
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    flaxseed
    2 interactions

    Monitor/Modify Tx

    sacubitril + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + flaxseed

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flibanserin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    flibanserin
    2 interactions

    Monitor/Modify Tx

    sacubitril + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • flucytosine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    valsartan + flucytosine

    monitor CBC, renal fxn, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fludrocortisone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    valsartan + fludrocortisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fluphenazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fluphenazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • formoterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + formoterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • foscarnet
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    valsartan + foscarnet

    monitor CBC, renal fxn: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • foslevodopa
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    foslevodopa
    2 interactions

    Monitor/Modify Tx

    sacubitril + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fostamatinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    valsartan + fostamatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fremanezumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    valsartan + fremanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • frovatriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + frovatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fruquintinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    valsartan + fruquintinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • furosemide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    furosemide
    2 interactions

    Monitor/Modify Tx

    sacubitril + furosemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + furosemide

    monitor renal fxn; consider decr. dose of one or both drugs: combo may incr. risk of renal impairment (additive effects)

  • gadobenate dimeglumine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    gadobenate dimeglumine
    1 interaction

    Monitor/Modify Tx

    valsartan + gadobenate dimeglumine

    monitor potassium: combo may incr. valsartan levels, risk of hyperkalemia, other adverse effects (MRP2-mediated transport possibly inhibited)

  • galcanezumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    valsartan + galcanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ganciclovir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ganciclovir
    1 interaction

    Monitor/Modify Tx

    valsartan + ganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • garlic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    garlic
    2 interactions

    Monitor/Modify Tx

    sacubitril + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension (additive effects)

  • gentamicin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    gentamicin
    1 interaction

    Monitor/Modify Tx

    valsartan + gentamicin

    monitor gentamicin levels, renal fxn, ototoxicity: combo may incr. gentamicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • gilteritinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    gilteritinib
    2 interactions

    Monitor/Modify Tx

    sacubitril + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + gilteritinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • glimepiride
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    valsartan + glimepiride

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • glipizide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    valsartan + glipizide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • glyburide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    valsartan + glyburide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • guanfacine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    guanfacine
    2 interactions

    Monitor/Modify Tx

    sacubitril + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • haloperidol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    haloperidol
    2 interactions

    Monitor/Modify Tx

    sacubitril + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hoodia
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    valsartan + hoodia

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydralazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hydralazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + hydralazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + hydralazine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • hydrochlorothiazide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hydrochlorothiazide
    2 interactions

    Monitor/Modify Tx

    sacubitril + hydrochlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + hydrochlorothiazide

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • hydrocodone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hydrocodone
    2 interactions

    Monitor/Modify Tx

    sacubitril + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydrocortisone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    valsartan + hydrocortisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydromorphone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hydromorphone
    2 interactions

    Monitor/Modify Tx

    sacubitril + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxocobalamin IV
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    valsartan + hydroxocobalamin IV

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibrutinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    valsartan + ibrutinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibuprofen lysine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    valsartan + ibuprofen lysine

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • ifosfamide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    valsartan + ifosfamide

    monitor CBC, renal, cardiac fxn: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • iloperidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iloperidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iloprost
    2 interactions

    Monitor/Modify Tx

    sacubitril + iloprost

    monitor BP; consider holding sacubitril during iloprost admin.: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + iloprost

    monitor BP; consider holding valsartan during iloprost admin.: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    imipramine
    2 interactions

    Monitor/Modify Tx

    sacubitril + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • immune globulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    valsartan + immune globulin

    monitor renal fxn; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • indapamide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    indapamide
    2 interactions

    Monitor/Modify Tx

    sacubitril + indapamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + indapamide

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • insulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    valsartan + insulin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • iodixanol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iodixanol
    1 interaction

    Monitor/Modify Tx

    valsartan + iodixanol

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • iohexol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    valsartan + iohexol

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iomeprol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iomeprol
    1 interaction

    Monitor/Modify Tx

    valsartan + iomeprol

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iopamidol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    valsartan + iopamidol

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • iopromide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iopromide
    1 interaction

    Monitor/Modify Tx

    valsartan + iopromide

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • iothalamate meglumine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    valsartan + iothalamate meglumine

    if IV iothalamate meglumine use, monitor renal function; retrograde cystography and cystourethrography use OK: combo may incr. risk of nephrotoxicity (additive effects)

  • ioversol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ioversol
    1 interaction

    Monitor/Modify Tx

    valsartan + ioversol

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • iron sucrose
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    iron sucrose
    2 interactions

    Monitor/Modify Tx

    sacubitril + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + iron sucrose

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoflurane
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    isoflurane
    2 interactions

    Monitor/Modify Tx

    sacubitril + isoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + isoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isosorbide dinitrate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    isosorbide dinitrate
    2 interactions

    Monitor/Modify Tx

    sacubitril + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isosorbide mononitrate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    isosorbide mononitrate
    2 interactions

    Monitor/Modify Tx

    sacubitril + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isradipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ketamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    valsartan + ketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • labetalol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    sacubitril + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lanreotide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    valsartan + lanreotide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • leflunomide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    valsartan + leflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lenvatinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    valsartan + lenvatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • levalbuterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + levalbuterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • levobunolol ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    levobunolol ophthalmic
    2 interactions

    Monitor/Modify Tx

    sacubitril + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • levodopa
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    levodopa
    2 interactions

    Monitor/Modify Tx

    sacubitril + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levomilnacipran
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    valsartan + levomilnacipran

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • levorphanol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    levorphanol
    2 interactions

    Monitor/Modify Tx

    sacubitril + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • levothyroxine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    valsartan + levothyroxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • licorice
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    valsartan + licorice

    monitor BP w/ large amounts of licorice: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lidocaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lidocaine
    2 interactions

    Monitor/Modify Tx

    sacubitril + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + lidocaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • liothyronine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    valsartan + liothyronine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lisdexamfetamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    valsartan + lisdexamfetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lithium
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    valsartan + lithium

    monitor lithium levels, renal fxn; consider decr. lithium start dose: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lomustine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    valsartan + lomustine

    monitor CBC, renal fxn: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • lopinavir/ritonavir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lopinavir/ ritonavir
    1 interaction

    Monitor/Modify Tx

    valsartan + lopinavir/ ritonavir

    monitor potassium: combo may incr. valsartan levels, risk of hyperkalemia, other adverse effects (hepatic transport inhibited)

  • lorlatinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    valsartan + lorlatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • loxapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    loxapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lubiprostone
    2 interactions

    Monitor/Modify Tx

    sacubitril + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • lumacaftor/ivacaftor
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    valsartan + lumacaftor/ ivacaftor

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumateperone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lumateperone
    2 interactions

    Monitor/Modify Tx

    sacubitril + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lurasidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • luspatercept
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    valsartan + luspatercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    valsartan + lutetium Lu 177 vipivotide tetraxetan

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium citrate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    valsartan + magnesium citrate

    monitor renal fxn, especially if magnesium citrate bowel prep use: combo may incr. risk of renal impairment (additive effects)

  • magnesium salicylate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    valsartan + magnesium salicylate

    monitor renal fxn, BP w/ high-dose magnesium salicylate: combo may incr. risk of renal impairment; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • magnesium sulfate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    magnesium sulfate
    2 interactions

    Monitor/Modify Tx

    sacubitril + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • maraviroc
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    maraviroc
    2 interactions

    Monitor/Modify Tx

    sacubitril + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meperidine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    meperidine
    2 interactions

    Monitor/Modify Tx

    sacubitril + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mepivacaine
    2 interactions

    Monitor/Modify Tx

    sacubitril + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + mepivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • mesalamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    valsartan + mesalamine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    valsartan + mesalamine rectal

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • methadone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methadone
    2 interactions

    Monitor/Modify Tx

    sacubitril + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methamphetamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    valsartan + methamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methohexital
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methohexital
    2 interactions

    Monitor/Modify Tx

    sacubitril + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + methohexital

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • methotrexate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    valsartan + methotrexate

    monitor CBC, renal fxn: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    valsartan + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methyldopa
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    sacubitril + methyldopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methylene blue injection
    2 interactions

    Monitor/Modify Tx

    sacubitril + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylergonovine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    valsartan + methylergonovine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylphenidate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    valsartan + methylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylprednisolone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    valsartan + methylprednisolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methyltestosterone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    valsartan + methyltestosterone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoclopramide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    valsartan + metoclopramide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metolazone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    metolazone
    2 interactions

    Monitor/Modify Tx

    sacubitril + metolazone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + metolazone

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • metoprolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • midazolam
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    midazolam
    2 interactions

    Monitor/Modify Tx

    sacubitril + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + midazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • midodrine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    midodrine
    1 interaction

    Monitor/Modify Tx

    valsartan + midodrine

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • milnacipran
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    valsartan + milnacipran

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milrinone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    milrinone
    2 interactions

    Monitor/Modify Tx

    sacubitril + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + milrinone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milsaperidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    milsaperidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • minoxidil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    sacubitril + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mirabegron
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    valsartan + mirabegron

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirtazapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mirtazapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mitomycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    valsartan + mitomycin

    monitor renal fxn; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • modafinil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    valsartan + modafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • molindone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    molindone
    2 interactions

    Monitor/Modify Tx

    sacubitril + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • momelotinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    sacubitril + momelotinib

    monitor CBC, bleeding s/sx: combo may incr. momelotinib levels, risk of serious infection, myelosuppression, other adverse effects (hepatic transport inhibited)

  • morphine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    morphine
    2 interactions

    Monitor/Modify Tx

    sacubitril + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nadolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + nadolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nalbuphine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nalbuphine
    2 interactions

    Monitor/Modify Tx

    sacubitril + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • naphazoline ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    naphazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    valsartan + naphazoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naratriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + naratriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nateglinide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nateglinide
    2 interactions

    Monitor/Modify Tx

    sacubitril + nateglinide

    monitor glucose: combo may incr. nateglinide levels, risk of hypoglycemia, other adverse effects (hepatic transport inhibited)

    valsartan + nateglinide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • nattokinase
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nattokinase
    2 interactions

    Monitor/Modify Tx

    sacubitril + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + nattokinase

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • naxitamab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    naxitamab
    2 interactions

    Monitor/Modify Tx

    sacubitril + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + naxitamab

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • nebivolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • neomycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    valsartan + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal fxn, ototoxicity: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • niacin (vitamin B3)
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    niacin (vitamin B3)
    2 interactions

    Monitor/Modify Tx

    sacubitril + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nicardipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nifedipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nimodipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • niraparib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    valsartan + niraparib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nisoldipine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    sacubitril + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitric oxide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nitric oxide
    2 interactions

    Monitor/Modify Tx

    sacubitril + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + nitric oxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitrite
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nitrite
    2 interactions

    Monitor/Modify Tx

    sacubitril + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

    valsartan + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nitroglycerin
    2 interactions

    Monitor/Modify Tx

    sacubitril + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nitroprusside
    2 interactions

    Monitor/Modify Tx

    sacubitril + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

    valsartan + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nortriptyline
    2 interactions

    Monitor/Modify Tx

    sacubitril + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nusinersen
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    valsartan + nusinersen

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • obinutuzumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    obinutuzumab
    2 interactions

    Monitor/Modify Tx

    sacubitril + obinutuzumab

    monitor BP; consider holding sacubitril x12h before and during obinutuzumab infusion: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + obinutuzumab

    monitor BP: combo may incr. risk of hypotension; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • olanzapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    olanzapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oliceridine
    2 interactions

    Monitor/Modify Tx

    sacubitril + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • olodaterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + olodaterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olsalazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    valsartan + olsalazine

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • opicapone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    opicapone
    2 interactions

    Monitor/Modify Tx

    sacubitril + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    opium
    2 interactions

    Monitor/Modify Tx

    sacubitril + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • osilodrostat
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    valsartan + osilodrostat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxaliplatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxaliplatin
    1 interaction

    Monitor/Modify Tx

    valsartan + oxaliplatin

    monitor ECG, CBC, renal fxn, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • oxazepam
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxazepam
    2 interactions

    Monitor/Modify Tx

    sacubitril + oxazepam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + oxazepam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • oxycodone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxycodone
    2 interactions

    Monitor/Modify Tx

    sacubitril + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxymetazoline nasal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    valsartan + oxymetazoline nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    valsartan + oxymetazoline ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline topical
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxymetazoline topical
    1 interaction

    Monitor/Modify Tx

    valsartan + oxymetazoline topical

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymorphone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxymorphone
    2 interactions

    Monitor/Modify Tx

    sacubitril + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxytocin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    valsartan + oxytocin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ozanimod
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    valsartan + ozanimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • paliperidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    paliperidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    palopegteriparatide
    2 interactions

    Monitor/Modify Tx

    sacubitril + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pamidronate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    valsartan + pamidronate

    monitor renal fxn: combo may incr. pamidronate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • paromomycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    valsartan + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal fxn, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pazopanib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    valsartan + pazopanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pemetrexed
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    valsartan + pemetrexed

    monitor CBC, renal fxn: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    valsartan + penicillamine

    monitor CBC, renal fxn: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentamidine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pentamidine
    2 interactions

    Monitor/Modify Tx

    sacubitril + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

    valsartan + pentamidine

    monitor renal fxn, BP: combo may incr. risk of nephrotoxicity, severe or life-threatening hypotension (additive effects)

  • pentazocine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pentazocine
    2 interactions

    Monitor/Modify Tx

    sacubitril + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pentobarbital
    2 interactions

    Monitor/Modify Tx

    sacubitril + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + pentobarbital

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • pentostatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    valsartan + pentostatin

    monitor CBC, renal fxn: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentoxifylline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    valsartan + pentoxifylline

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • perphenazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    perphenazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pexidartinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    valsartan + pexidartinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phendimetrazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    valsartan + phendimetrazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenelzine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenelzine
    2 interactions

    Monitor/Modify Tx

    sacubitril + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenobarbital
    2 interactions

    Monitor/Modify Tx

    sacubitril + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenoxybenzamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    sacubitril + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentermine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    valsartan + phentermine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentolamine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    sacubitril + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenylephrine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    valsartan + phenylephrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine injection
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    valsartan + phenylephrine injection

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • phenylephrine nasal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    valsartan + phenylephrine nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    valsartan + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine rectal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    valsartan + phenylephrine rectal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pindolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + pindolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pitavastatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pitavastatin
    1 interaction

    Monitor/Modify Tx

    sacubitril + pitavastatin

    monitor CK, myopathy sx: combo may incr. pitavastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (hepatic transport inhibited)

  • plazomicin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    valsartan + plazomicin

    monitor plazomicin levels, renal fxn, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • polyethylene glycol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    valsartan + polyethylene glycol

    monitor renal fxn, especially if polyethylene glycol bowel prep use: combo may incr. risk of renal impairment (additive effects)

  • polyethylene glycol/electrolytes
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    valsartan + polyethylene glycol/ electrolytes

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • polymyxin B
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    polymyxin B
    1 interaction

    Monitor/Modify Tx

    valsartan + polymyxin B

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ponatinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    valsartan + ponatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ponesimod
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    valsartan + ponesimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pralsetinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    valsartan + pralsetinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pramipexole
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pramipexole
    2 interactions

    Monitor/Modify Tx

    sacubitril + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pravastatin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pravastatin
    1 interaction

    Monitor/Modify Tx

    sacubitril + pravastatin

    monitor CK, myopathy sx: combo may incr. pravastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (hepatic transport inhibited)

  • prazosin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    prazosin
    2 interactions

    Monitor/Modify Tx

    sacubitril + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prednisolone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    valsartan + prednisolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    valsartan + prednisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pretomanid
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pretomanid
    1 interaction

    Monitor/Modify Tx

    valsartan + pretomanid

    monitor potassium: combo may incr. valsartan levels, risk of hyperkalemia, other adverse effects (hepatic transport possibly inhibited)

  • procarbazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    procarbazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + procarbazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + procarbazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • prochlorperazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    prochlorperazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    promethazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + promethazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + promethazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propafenone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    propafenone
    2 interactions

    Monitor/Modify Tx

    sacubitril + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + propafenone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propofol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    propofol
    2 interactions

    Monitor/Modify Tx

    sacubitril + propofol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + propofol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • propranolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • protriptyline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    protriptyline
    2 interactions

    Monitor/Modify Tx

    sacubitril + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pseudoephedrine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    valsartan + pseudoephedrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quetiapine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    quetiapine
    2 interactions

    Monitor/Modify Tx

    sacubitril + quetiapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + quetiapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antihypertensive agent efficacy (peds patients) (additive effects)

  • ramucirumab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    valsartan + ramucirumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • rasagiline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    rasagiline
    2 interactions

    Monitor/Modify Tx

    sacubitril + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • regorafenib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    valsartan + regorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • remifentanil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    remifentanil
    2 interactions

    Monitor/Modify Tx

    sacubitril + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    remimazolam
    2 interactions

    Monitor/Modify Tx

    sacubitril + remimazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + remimazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • repaglinide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    repaglinide
    2 interactions

    Monitor/Modify Tx

    sacubitril + repaglinide

    monitor glucose: combo may incr. repaglinide levels, risk of hypoglycemia, other adverse effects (hepatic transport inhibited)

    valsartan + repaglinide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • Rho(D) immune globulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    valsartan + Rho(D) immune globulin

    monitor renal fxn; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • rifampin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    rifampin
    2 interactions

    Monitor/Modify Tx

    valsartan + rifampin

    monitor potassium: combo may incr. valsartan levels, risk of hyperkalemia, other adverse effects (hepatic transport inhibited)

    Caution Advised

    sacubitril + rifampin

    caution advised: combo may incr. rifampin levels, risk of adverse effects (hepatic transport inhibited)

  • rimegepant
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    valsartan + rimegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • riociguat
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    riociguat
    2 interactions

    Monitor/Modify Tx

    sacubitril + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + riociguat

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ripretinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    valsartan + ripretinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • risperidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    risperidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ritonavir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ritonavir
    1 interaction

    Monitor/Modify Tx

    valsartan + ritonavir

    monitor potassium: combo may incr. valsartan levels, risk of hyperkalemia, other adverse effects (MRP2-mediated transport inhibited)

  • rituximab
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    valsartan + rituximab

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • rizatriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + rizatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ropeginterferon alfa-2b
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    valsartan + ropeginterferon alfa-2b

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ropinirole
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ropinirole
    2 interactions

    Monitor/Modify Tx

    sacubitril + ropinirole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + ropinirole

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • ropivacaine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ropivacaine
    2 interactions

    Monitor/Modify Tx

    sacubitril + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + ropivacaine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • rotigotine transdermal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    rotigotine transdermal
    2 interactions

    Monitor/Modify Tx

    sacubitril + rotigotine transdermal

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + rotigotine transdermal

    monitor BP: combo may alter blood pressure control (antagonistic effects, additive effects)

  • sacubitril
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    valsartan + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    safinamide
    2 interactions

    Monitor/Modify Tx

    sacubitril + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • salmeterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + salmeterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • salsalate
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    valsartan + salsalate

    monitor BP, renal fxn: combo may decr. antihypertensive agent efficacy; may incr. risk of renal impairment (antagonistic effects; additive effects)

  • selegiline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    selegiline
    2 interactions

    Monitor/Modify Tx

    sacubitril + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    selegiline transdermal
    2 interactions

    Monitor/Modify Tx

    sacubitril + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selpercatinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    valsartan + selpercatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sevoflurane
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sevoflurane
    2 interactions

    Monitor/Modify Tx

    sacubitril + sevoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + sevoflurane

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sildenafil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sildenafil
    2 interactions

    Monitor/Modify Tx

    sacubitril + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + sildenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • silodosin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    silodosin
    2 interactions

    Monitor/Modify Tx

    sacubitril + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • siponimod
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    valsartan + siponimod

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sirolimus
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    valsartan + sirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sitagliptin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    valsartan + sitagliptin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sodium ferric gluconate complex
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sodium ferric gluconate complex
    2 interactions

    Monitor/Modify Tx

    sacubitril + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sorafenib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    valsartan + sorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sotagliflozin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sotagliflozin
    2 interactions

    Monitor/Modify Tx

    sacubitril + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sotalol
    2 interactions

    Monitor/Modify Tx

    sacubitril + sotalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + sotalol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • streptomycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    streptomycin
    1 interaction

    Monitor/Modify Tx

    valsartan + streptomycin

    monitor renal fxn, ototoxicity: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    streptozocin
    1 interaction

    Monitor/Modify Tx

    valsartan + streptozocin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sufentanil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sufentanil
    2 interactions

    Monitor/Modify Tx

    sacubitril + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • sulfate bowel prep
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    valsartan + sulfate bowel prep

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • sumatriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + sumatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sunitinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    valsartan + sunitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tadalafil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tadalafil
    2 interactions

    Monitor/Modify Tx

    sacubitril + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + tadalafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tagraxofusp
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tagraxofusp
    2 interactions

    Monitor/Modify Tx

    sacubitril + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + tagraxofusp

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • tamsulosin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tamsulosin
    2 interactions

    Monitor/Modify Tx

    sacubitril + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tapentadol
    2 interactions

    Monitor/Modify Tx

    sacubitril + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    taurine
    2 interactions

    Monitor/Modify Tx

    sacubitril + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + taurine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • telavancin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    valsartan + telavancin

    monitor ECG, renal fxn: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • temsirolimus
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    valsartan + temsirolimus

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    valsartan + tenofovir alafenamide

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tenofovir disoproxil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    valsartan + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • terazosin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    terazosin
    2 interactions

    Monitor/Modify Tx

    sacubitril + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbutaline
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    valsartan + terbutaline

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • teriflunomide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    valsartan + teriflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • testosterone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    valsartan + testosterone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tetrahydrozoline ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    valsartan + tetrahydrozoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • thalidomide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    thalidomide
    2 interactions

    Monitor/Modify Tx

    sacubitril + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    thioridazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    thiothixene
    2 interactions

    Monitor/Modify Tx

    sacubitril + thiothixene

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + thiothixene

    monitor BP: combo may incr. risk of hypotension, syncope (additive effects)

  • thyroid
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    valsartan + thyroid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • timolol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    sacubitril + timolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • timolol ophthalmic
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    timolol ophthalmic
    2 interactions

    Monitor/Modify Tx

    sacubitril + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tiopronin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    valsartan + tiopronin

    monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tivozanib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    valsartan + tivozanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tizanidine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tizanidine
    2 interactions

    Monitor/Modify Tx

    sacubitril + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tobramycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tobramycin
    1 interaction

    Monitor/Modify Tx

    valsartan + tobramycin

    monitor tobramycin levels, renal fxn, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tobramycin inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + tobramycin inhaled

    monitor renal fxn, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tolcapone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tolcapone
    2 interactions

    Monitor/Modify Tx

    sacubitril + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    torsemide
    2 interactions

    Monitor/Modify Tx

    sacubitril + torsemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + torsemide

    monitor renal fxn: combo may incr. risk of renal impairment (additive effects)

  • tramadol
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tramadol
    2 interactions

    Monitor/Modify Tx

    sacubitril + tramadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + tramadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • trametinib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    valsartan + trametinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tranylcypromine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    tranylcypromine
    2 interactions

    Monitor/Modify Tx

    sacubitril + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    trazodone
    2 interactions

    Monitor/Modify Tx

    sacubitril + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    treprostinil
    2 interactions

    Monitor/Modify Tx

    sacubitril + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

    valsartan + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • triamcinolone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    valsartan + triamcinolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trifluoperazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    trifluoperazine
    2 interactions

    Monitor/Modify Tx

    sacubitril + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

    valsartan + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    trimipramine
    2 interactions

    Monitor/Modify Tx

    sacubitril + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ubrogepant
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    valsartan + ubrogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vaccinia immune globulin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vaccinia immune globulin
    1 interaction

    Monitor/Modify Tx

    valsartan + vaccinia immune globulin

    monitor renal fxn; use lowest vaccinia immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • vadadustat
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    valsartan + vadadustat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • valacyclovir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    valsartan + valacyclovir

    monitor renal fxn: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valganciclovir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    valganciclovir
    1 interaction

    Monitor/Modify Tx

    valsartan + valganciclovir

    monitor CBC, renal fxn: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • vamorolone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    valsartan + vamorolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vancomycin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    valsartan + vancomycin

    VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity; VANCOMYCIN PO: consider monitoring renal fxn, vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • vandetanib
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    valsartan + vandetanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vardenafil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vardenafil
    2 interactions

    Monitor/Modify Tx

    sacubitril + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + vardenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • vasopressin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    valsartan + vasopressin

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • venlafaxine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    valsartan + venlafaxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • verapamil
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    sacubitril + verapamil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vericiguat
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vericiguat
    1 interaction

    Monitor/Modify Tx

    sacubitril + vericiguat

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vilanterol inhaled
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    valsartan + vilanterol inhaled

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • viloxazine
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    valsartan + viloxazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vosoritide
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    vosoritide
    2 interactions

    Monitor/Modify Tx

    sacubitril + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + vosoritide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • willow bark
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    valsartan + willow bark

    monitor renal fxn, especially w/ high-dose willow bark: combo may incr. risk of renal impairment (additive effects, willow bark may contain salicylates)

  • yohimbe
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    yohimbe
    2 interactions

    Monitor/Modify Tx

    sacubitril + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis (additive effects)

    valsartan + yohimbe

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • ziprasidone
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ziprasidone
    2 interactions

    Monitor/Modify Tx

    sacubitril + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

    valsartan + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ziv-aflibercept
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    valsartan + ziv-aflibercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zoledronic acid
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    valsartan + zoledronic acid

    monitor renal fxn: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zolmitriptan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    valsartan + zolmitriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Caution Advised

  • bosentan
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    bosentan
    1 interaction

    Caution Advised

    sacubitril + bosentan

    caution advised: combo may incr. bosentan levels, risk of adverse effects (hepatic transport inhibited)

  • eltrombopag
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    eltrombopag
    1 interaction

    Caution Advised

    valsartan + eltrombopag

    caution advised: combo may incr. valsartan levels, risk of adverse effects (hepatic transport possibly inhibited)

  • glecaprevir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    glecaprevir
    1 interaction

    Caution Advised

    sacubitril + glecaprevir

    caution advised: combo may incr. glecaprevir levels, risk of adverse effects (hepatic transport inhibited)

  • pregabalin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    pregabalin
    1 interaction

    Caution Advised

    sacubitril + pregabalin

    caution advised: combo may incr. risk of angioedema (additive effects)

  • verteporfin
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    verteporfin
    1 interaction

    Caution Advised

    sacubitril + verteporfin

    caution advised: combo may decr. verteporfin efficacy (mechanism unknown)

  • voxilaprevir
  • Entresto Sprinkle (sacubitril/ valsartan)
    +
    voxilaprevir
    1 interaction

    Caution Advised

    sacubitril + voxilaprevir

    caution advised: combo may incr. voxilaprevir levels, risk of adverse effects (hepatic transport inhibited)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@12c1f8e
  • hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • bullous dermatitis
  • hypotension, severe
  • hyperkalemia
  • renal impairment
  • renal failure
  • neutropenia
  • thrombocytopenia
  • hepatitis
  • rhabdomyolysis

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@7e1f97c
  • hypotension
  • Cr incr.
  • hyperkalemia
  • cough
  • Hgb decr.
  • Hct decr.
  • dizziness
  • renal failure
  • hypotension, orthostatic

Safety/Monitoring .

Monitoring Parameters
BUN/Cr at baseline, then periodically; electrolytes; BP

Pregnancy/Lactation .

Pregnancy

Clinical Summary

avoid use during pregnancy; if must use, monitor amniotic fluid and fetus closely; risk of fetal and neonatal harm, including intrauterine growth restriction, oligohydramnios, renal failure, and death, in 2nd and 3rd trimesters based on human data and drug's mechanism of action

Lactation

Clinical Summary

avoid use while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@6672f15

Metabolism: for sacubitril: minimal; CYP450: minimal; for valsartan: liver; CYP450: 2C9 substrate

Excretion: for sacubitril: urine 52-68%, feces 37-48%; Half-life: 11.5h; for valsartan: feces 86%, urine 13% (10% unchanged); Half-life: 9.9h

Subclass: Angiotensin Receptor Blockers (ARBs) ; Neprilysin Inhibitors

Mechanism of Action
for sacubitril: prodrug converted to active metabolite, which inhibits neprilysin, decreasing natriuretic peptide degradation; for valsartan: selectively antagonizes angiotensin II AT1 receptors

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Novartis Pharmaceuticals Corp.

com.epocrates.rxweb.beans.DrugOtherInfoBean@57568119

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information